NASDAQ: PPBT
Purple Biotech Ltd Stock Ownership - Who owns Purple Biotech?

Insider buying vs selling

Have Purple Biotech Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PPBT insiders and whales buy or sell their stock.

PPBT Shareholders

What type of owners hold Purple Biotech Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ubs Group Ag0.00%23,025$55.26kInstitution
Kingswood Wealth Advisors LLC0.00%16,797$40.31kInstitution
Bnp Paribas Financial Markets0.00%5,375$12.90kInstitution
Morgan Stanley0.00%4,466$10.72kInstitution
Rhumbline Advisers0.00%805$1.93kInstitution
Royal Bank Of Canada0.00%107$256.80Institution
Northwestern Mutual Wealth Management Co0.00%85$204.00Institution
Sbi Securities Co Ltd0.00%20$48.00Institution
North Star Investment Management Corp0.00%15$36.00Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

PPBT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PPBT0.01%0.00%
SEER46.79%52.88%Net SellingNet Selling
SKYE3.37%96.63%Net Selling
ATOS21.95%11.04%Net BuyingNet Buying
ACTU25.38%74.62%Net BuyingNet Buying

Purple Biotech Stock Ownership FAQ

Who owns Purple Biotech?

Purple Biotech (NASDAQ: PPBT) is owned by 0.01% institutional shareholders, 0.00% Purple Biotech insiders, and 99.99% retail investors. Ubs Group Ag is the largest individual Purple Biotech shareholder, owning 23,025.00 shares representing 0.00% of the company. Ubs Group Ag's Purple Biotech shares are currently valued at $55.26k.

If you're new to stock investing, here's how to buy Purple Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.